Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 14/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | MLNR | O43193 | 1/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.37 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.37 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.37 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.37 |
| ▸ | CCKAR | P32238 | 1/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | GHSR | Q92847 | 1/20 | 0.37 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.37 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.37 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.37 |
| ▸ | CTSE | P14091 | 1/20 | 0.36 |
| ▸ | PGC | P20142 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3551999 | 1.00 | CTSD (0.38) | CTSDCYP3A4MLNRNR1I2SLCO2B1 | |
| SCHEMBL3554925 | 0.96 | UGT1A1 (0.41) | CTSDCYP3A4MLNRNR1I2SLCO2B1 | |
| SCHEMBL3551453 | 0.95 | CTSD (0.39) | CTSDCYP3A4MLNRNR1I2SLCO2B1 | |
| SCHEMBL3552103 | 0.93 | UGT1A1 (0.42) | CTSDCYP3A4MLNRNR1I2SLCO2B1 | |
| SCHEMBL3546804 | 0.92 | UGT1A1 (0.46) | CTSDCYP3A4MLNRNR1I2SLCO2B1 | |
| SCHEMBL3552836 | 0.91 | MLNR (0.37) | CTSDCYP3A4MLNRNR1I2SLCO2B1 | |
| SCHEMBL3550196 | 0.90 | UGT1A1 (0.51) | CTSDCYP3A4MLNRNR1I2SLCO2B1 | |
| SCHEMBL3547685 | 0.90 | UGT1A1 (0.48) | CTSDCYP3A4MLNRNR1I2SLCO2B1 | |
| SCHEMBL5719640 | 0.89 | CTSD (0.36) | CTSDCYP3A4MLNRNR1I2SLCO2B1 | |
| SCHEMBL3552257 | 0.89 | CTSD (0.37) | CTSDCYP3A4CTSEPGC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1697348-B1 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LAB (US) | 2011-12-28 | — | — | EP | disclosed |
| US-7696226-B2 | HIV protease inhibiting compounds | ABBOTT LABORATORIES (US) | 2010-04-13 | — | — | US | disclosed |
| US-20050159469-A1 | HIV protease inhibiting compounds | ABBVIE INC. | 2005-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159469-A1 | HIV protease inhibiting compounds | SERPINB1, HPN, DNPEP | CTSD 84/4885CYP3A4 764/4885MLNR 3723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.